Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Chief Financial Officer, Mark Dmytruk, is scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6 at 11:30 a.m. ET.
2024年8月30日波士頓/美通社/ — 生物工程公司Ginkgo Bioworks Holdings, Inc. (紐交所: DNA)已經開始建立領先的電芯編程和生物安全平台。今天宣佈首席財務官Mark Dmytruk將參加摩根士丹利全球第22屆醫療保健年會的座談會，時間爲9月6日星期五上午11點30分Et。
Further details, a webcast link, and a replay of the fireside chat will be posted on the company's investor relations website at .
更多詳細信息、網絡直播鏈接以及座談會的回放將發佈在公司的投資者關係網站上。 .
About Ginkgo Bioworks
Ginkgo Bioworks 正在建立一個平台，使客戶能夠像編程計算機一樣編程細胞。公司的平台正在實現在各個市場中應用生物技術，從食品和農業到工業化學品再到製藥業。Ginkgo 還積極支持多項 COVID-19 應對舉措，包括 K-12 商湯測試、疫苗製造優化和治療發現等。有關更多信息，請訪問:
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks是領先的電芯編程水平開放平台，提供靈活的端到端服務，爲食品和農業、製藥、製造行業和特種化學品等各種市場的組織解決挑戰。Ginkgo Biosecurity正在構建和部署全球領導者需要預測、檢測和應對各種生物威脅的下一代基礎設施和技術。更多信息，請訪問 ginkgobioworks.com和頁面。ginkgobiosecurity.com閱讀我們博客，或在社交媒體頻道關注我們，如X（@Ginkgo），(@ConcentricByGBW)Ginkgo和銀杏生物安全），Instagram（@GinkgoBioworks），Threads（@GinkgoBioworks）或GinkgoBioworks）GinkgoBioworks或LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
投資者聯繫方式：
[email protected]
[email protected]
MEDIA CONTACT:
媒體聯繫人：
[email protected]
[email protected]
SOURCE Ginkgo Bioworks
源自Ginkgo Bioworks
